S. Gong

发表

Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2

M. Pazgier, C. Abrams, J. Richard, 2021, bioRxiv.

VE607 stabilizes SARS-CoV-2 Spike in the “RBD-up” conformation and inhibits viral entry

D. Vézina, P. Uchil, C. Baron, 2022, iScience.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2022, Cell reports.

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2021, bioRxiv.

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2021, Cell Reports Medicine.

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2022, iScience.

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2022, bioRxiv.

Molecular basis for antiviral activity of pediatric neutralizing antibodies targeting SARS-CoV-2 Spike receptor binding domain

D. Vézina, E. Haddad, P. Uchil, 2022, bioRxiv.

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2

D. Vézina, M. Pazgier, J. Richard, 2022, Viruses.

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells

J. Richard, Shilei Ding, S. Anand, 2021, Viruses.

Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer

Jingen Hu, S. Gong, Xueying Zhou, 2020 .

Stabilizing the HIV-1 Envelope Glycoprotein State 2A Conformation

D. Vézina, M. Pazgier, W. Tolbert, 2020, Journal of Virology.

Across functional boundaries: making non-neutralizing antibodies to neutralize HIV-1 and mediate Fc-mediated effector killing of infected cells

D. Vézina, M. Pazgier, W. Tolbert, 2021, bioRxiv.

Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD

D. Vézina, E. Haddad, P. Uchil, 2022, iScience.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, bioRxiv.

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, Cell Host and Microbe.

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

D. Vézina, L. Stamatatos, V. Martel-Laferrière, 2021, Cell Host & Microbe.

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2

M. Pazgier, C. Abrams, J. Richard, 2021, Journal of Biological Chemistry.

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

D. Vézina, Shijian Zhang, J. Sodroski, 2021, Cell Reports.

Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity

D. Vézina, J. Richard, J. Prévost, 2021, bioRxiv.

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern

D. Vézina, Shijian Zhang, J. Sodroski, 2021, bioRxiv.

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, bioRxiv.

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

D. Vézina, L. Stamatatos, V. Martel-Laferrière, 2021, bioRxiv.

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2023, Cell reports.

SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2023, Cell Reports.

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

D. Vézina, L. Stamatatos, P. Uchil, 2022, Cell Reports.

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

Justine C. Williams, E. Wherry, V. Martel-Laferrière, 2022, Cell Reports.

VE607 Stabilizes SARS-CoV-2 Spike In the “RBD-up” Conformation and Inhibits Viral Entry

D. Vézina, C. Baron, M. Pazgier, 2022, bioRxiv.

An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice

D. Vézina, L. Stamatatos, P. Uchil, 2021, bioRxiv.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2022, Cell reports.

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes

J. Richard, H. Medjahed, G. Gendron-Lepage, 2022, Viruses.